|
Antiplatelet agent subgroup
|
No. of enrolled studies
|
No. of events due to DB (deaths or neurosurgery)
|
No. of patients at risk
|
CRDB mean estimated risk (95% CI)
|
|---|
|
All
|
16
|
5
|
2930
|
0.17% (0.06–0.40%)
|
|
ASA
|
11
|
3
|
1706
|
0.18% (0.04–0.51%)
|
|
Clopidogrel
|
9
|
0
|
265
|
0.00% (0.00–1.38%)
|
|
DAPT
|
6
|
0
|
175
|
0.00% (0.00–2.09%)
|
- CRDB = clinically relevant delayed bleeding as defined in the text; 95% CI = 95% confidence interval; All = all patients included in the analysis; ASA = acetylsalicylic acid; DAPT = dual antiplatelet therapy
